# Arcutis Biotherapeutics, Inc. (ARQT)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/ARQT/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 235.26M | $ 3.71M | $ 14.72M | $ 114.14M | $ 220.58M |
| 2025 | $ 385.06M | $ -16.53M | $ -6.46M | N/A | $ 189.48M |
| 2024 | $ 206.58M | $ -147.19M | $ -123.29M | $ 110.59M | $ 157.54M |
| 2023 | $ 64.45M | $ -283.05M | $ -267.59M | $ 205.92M | $ 88.67M |
| 2022 | $ 4.12M | $ -347.93M | $ -313.90M | $ 202.54M | $ 209.58M |
| 2021 | $ 0 | $ -245.29M | $ -208.75M | $ 77.56M | $ 297.68M |
| 2020 | $ 0 | $ -172.84M | $ -145.01M | $ 4.96M | $ 270.62M |
| 2019 | $ 0 | $ -54.21M | $ -55.67M | $ 307.0K | $ 101.46M |
| 2018 | $ 0 | $ -25.43M | $ -18.60M | $ 0 | $ -23.99M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.52 |
| Liabilities / Eq | 1.21 |
| Current Ratio | 2.92 |

## Other views

- [Metrics](https://sponda.capital/en/ARQT.md)
- [Charts](https://sponda.capital/en/ARQT/charts.md)
- [Compare](https://sponda.capital/en/ARQT/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.